Glucose-dependent insulinotropic polypeptide promotes beta-(INS-1) cell survival via cyclic adenosine monophosphate-mediated caspase-3 inhibition and regulation of p38 mitogen-activated protein kinase
[5] [6] This approach typically results in a safe, sustainable weight loss of approximately 0.5 to 1 kg per week
Any persistent abnormalities should be reported to a GP or diabetes specialist nurse
Now, not only because I'm on a GLP-1, but as a woman in her 40s, I start my day with a protein smoothie
Common Side Effects and Safety Considerations Gastrointestinal side effects are the most frequently reported adverse reactions with GLP-1 receptor agonists, affecting a substantial proportion of patients, particularly during treatment initiation
It may also contribute to promoting insulin sensitivity and supporting healthy metabolic function